Publications dans lesquelles il/elle collabore avec Rosa del Campo Moreno (71)

2024

  1. A long-term survey of Serratia spp. bloodstream infections revealed an increase of antimicrobial resistance involving adult population

    Microbiology Spectrum, Vol. 12, Núm. 2

  2. Corrigendum to “Propensity-Score Analysis Reveals that Sex is Not a Prognostic Factor for Mortality in Intensive Care Unit-Admitted Patients with Septic Bacteremia” [International Journal of Infectious Diseases, volume 110 (2021) pages 36-44, (S1201971221005907), (10.1016/j.ijid.2021.07.034)]

    International Journal of Infectious Diseases

2023

  1. Automatic Discrimination of Species within the Enterobacter cloacae Complex Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Supervised Algorithms

    Journal of clinical microbiology, Vol. 61, Núm. 4, pp. e0104922

  2. The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification

    Infection and immunity, Vol. 91, Núm. 2, pp. e0001223

2022

  1. Correction to: Evaluation of CHROMagar™-Serratia agar, a new chromogenic medium for the detection and isolation of Serratia marcescens (European Journal of Clinical Microbiology & Infectious Diseases, (2021), 40, 12, (2593-2596), 10.1007/s10096-021-04328-w)

    European Journal of Clinical Microbiology and Infectious Diseases

  2. Strain-specific predation of Bdellovibrio bacteriovorus on Pseudomonas aeruginosa with a higher range for cystic fibrosis than for bacteremia isolates

    Scientific Reports, Vol. 12, Núm. 1

  3. The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives

    Microorganisms, Vol. 10, Núm. 4

2021

  1. An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis

    Frontiers in Immunology, Vol. 12

  2. Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates

    Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 10, pp. 2578-2585

  3. Characterization of carbapenemase-producing Serratia marcescens and whole-genome sequencing for plasmid typing in a hospital in Madrid, Spain (2016-18)

    Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 1, pp. 110-116

  4. Emergence and Persistence over Time of Carbapenemase-Producing Enterobacter Isolates in a Spanish University Hospital in Madrid, Spain (2005-2018)

    Microbial Drug Resistance, Vol. 27, Núm. 7, pp. 895-903

  5. Evaluation of CHROMagar™-Serratia agar, a new chromogenic medium for the detection and isolation of Serratia marcescens

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 12, pp. 2593-2596

  6. Long-term impact of suppressive antibiotic therapy on intestinal microbiota

    Genes, Vol. 12, Núm. 1, pp. 1-13

  7. Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 4, pp. 984-992

  8. Propensity-Score Analysis Reveals that Sex is Not a Prognostic Factor for Mortality in Intensive Care Unit-Admitted Patients with Septic Bacteremia

    International Journal of Infectious Diseases, Vol. 110, pp. 36-44

2020

  1. A publicly accessible database for clostridioides difficile genome sequences supports tracing of transmission chains and epidemics

    Microbial Genomics, Vol. 6, Núm. 8, pp. 1-13

  2. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162

2019

  1. Whole-genome sequencing reveals nosocomial Clostridioides difficile transmission and a previously unsuspected epidemic scenario

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals

    Microbial Drug Resistance, Vol. 24, Núm. 1, pp. 48-54

2017

  1. Antibiotic prescription patterns in Spanish cystic fibrosis patients: Results from a national multicenter study

    Farmacia Hospitalaria, Vol. 41, Núm. 3, pp. 391-400